Please login to the form below

Not currently logged in
Email:
Password:

vaccines

This page shows the latest vaccines news and features for those working in and with pharma, biotech and healthcare.

May’s Brexit plan cautiously welcomed by biopharma sector

May’s Brexit plan cautiously welcomed by biopharma sector

Our industry’s priority throughout these negotiations is to ensure patients in both the UK and EU can continue to access the medicine and vaccines they need.”.

Latest news

More from news
Approximately 106 fully matching, plus 1,027 partially matching documents found.

Latest Intelligence

  • Advancing women in healthcare Advancing women in healthcare

    She joined Merck &Co in 2009 and sees her role in promoting vaccines and facilitating greater access to them in all parts of the world as an extension of this same ... Dr Priya Agrawal is Business Unit Director, Vaccines &Women’s Health at MSD.

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Newer plans to lower the QALY for vaccines to £15, 000 should alarm all companies, as it suggests that the QALY for all medicines could also be lowered. ... This is essential. Vaccines are an interesting case study for the post-Brexit world.

  • Health on instalment Health on instalment

    The only apt parallel might be the discovery of antibiotics or vaccines, but even those milestones may end up paling in comparison.

  • Deal Watch January 2018

    Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales of GSK's QS-21 containing vaccines. ... In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.

  • The good, the bad and the ugly The good, the bad and the ugly

    This was driven largely by higher-than-expected sales of its pneumonia vaccine, Prevnar, which accounted for more than 11% of its total revenues in the third quarter of 2017.

More from intelligence
Approximately 5 fully matching, plus 74 partially matching documents found.

Latest appointments

More from appointments
Approximately 5 fully matching, plus 61 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 25 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics